Cargando…
Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen–urokinase plasminogen activator receptor system–regulated secretion during breast cancer progression
INTRODUCTION: Interleukin-like epithelial-to-mesenchymal transition inducer (ILEI) is an essential cytokine in tumor progression that is upregulated in several cancers, and its altered subcellular localization is a predictor of poor survival in human breast cancer. However, the regulation of ILEI ac...
Autores principales: | Csiszar, Agnes, Kutay, Betül, Wirth, Silvia, Schmidt, Ulrike, Macho-Maschler, Sabine, Schreiber, Martin, Alacakaptan, Memetcan, Vogel, Georg F, Aumayr, Karin, Huber, Lukas A, Beug, Hartmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303039/ https://www.ncbi.nlm.nih.gov/pubmed/25212966 http://dx.doi.org/10.1186/s13058-014-0433-7 |
Ejemplares similares
-
Annexin A1 attenuates EMT and metastatic potential in breast cancer
por: Maschler, Sabine, et al.
Publicado: (2010) -
Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995) -
In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008) -
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017) -
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants
Publicado: (1989)